Hypothesis: Primary antiangiogenic method proposed to treat early stage breast cancer

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Retsky, Michael W ^a   Hrushesky, William J M ^b   Gukas, Isaac D ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANGIOGENESIS INHIBITOR; ANGIOSTATIN; BEVACIZUMAB; CELECOXIB; ENDOSTATIN; INDOMETACIN; SUNITINIB; TAMOXIFEN; THROMBOSPONDIN; TUMSTATIN; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC THERAPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; DOWN REGULATION; DOWN SYNDROME; DRUG HALF LIFE; EARLY DIAGNOSIS; EARLY INTERVENTION; HUMAN; MAMMOGRAPHY; MICROMETASTASIS; PRIMARY TUMOR; TRISOMY 21; UPREGULATION; WOUND HEALING; BIOLOGICAL MODEL; BREAST TUMOR; COMPUTER SIMULATION; DRUG EFFECT; FEMALE; GENETICS; NEOVASCULARIZATION (PATHOLOGY); PREMEDICATION;

ANGIOGENESIS INHIBITORS; BREAST NEOPLASMS; COMPUTER SIMULATION; DOWN SYNDROME; ENDOSTATINS; FEMALE; HUMANS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; PREMEDICATION; WOUND HEALING;

EID: 60649118379     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-7     Document Type: Article

References (40)

1. American Cancer Society Breast Cancer Facts and Figures 2008 http://www.cancer.org/downloads/STT/BCFF-Final.pdf
2. Retsky MW Demicheli R Swartzendruber DE Bame PD Wardwell RH Bonadonna G Speer J Valagussa P Computer simulation of a breast cancer metastasis model Breast Cancer Research and Treatment 1997, 45:193-202. 10.1023/ A:1005849301420
3. Demicheli R Retsky M Swartzendruber D Bonadonna G Proposal for a new model of breast cancer metastatic development Annals of Oncology 1997, 8:1075-1080. 10.1023/A:1008263116022 9426326
4. Meng S Tripathy D Frenkel EP Shete S Naftalis EZ Huth JF Beitsch PD Leitch M Hoover S Euhus D Haley B Morrison L Fleming TP Herlyn D Terstappen LW Fehm T Tucker TF Lane N Wang J Uhr JW Circulating tumor cells in patients with breast cancer dormancy Clin Cancer Res 2004, 10(24):8152-8162. 10.1158/1078-0432.CCR-04-1110 15623589
5. Retsky M Demicheli R Hrushesky W Premenopausal status accelerates relapse in node positive breast cancer: Hypothesis links angiogenesis, screening controversy Breast Cancer Research and Treatment 2001, 65:217-224. 10.1023/A:1010626302152
6. Demicheli R Retsky MW Hrushesky WJ Baum M Tumor dormancy and surgical interruption of dormancy in breast cancer: Learning from failures Nature - Clinical Practice of Oncology 2007, 4:699-710. 10.1038/ncponc0999
7. Retsky M Demicheli R Hrushesky W Breast cancer screening: Controversies and future directions Current Opinion in Obstetrics and Gynecology 2003, 15:1-8. 10.1097/00001703-200302000-00001
8. Demicheli R Bonadonna G Hrushesky WJM Retsky MW Valagussa P Menopausal status dependence of the early mortality reduction due to diagnosing smaller breast cancers (T1 versus T2-T3): Relevance to screening J Clin Oncol 2004, 22(1):102-107. 10.1200/JCO.2004.12.139 14701771
9. Retsky M Demicheli R Hrushesky WJM Does surgery induce angiogenesis in breast cancer? Indirect evidence from relapse pattern and mammography paradox International Journal of Surgery 2005, 3(3):179-187. 10.1016/ j.ijsu.2005.08.002 17462282
10. O'Reilly MS Holmgren L Shing Y Chen C Rosenthal RA Moses M Lane WS Cao Y Sage EH Folkman J Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 1994, 79(2):315-328. 10.1016/0092-8674(94)90200-3 7525077
11. Retsky MW Demicheli R Gukas ID Hrushesky WJ Enhanced surgery-induced angiogenesis among premenopausal women might partially explain excess breast cancer mortality of blacks compared to whites: An hypothesis Int J Surg 2007, 5(5):300-304. 10.1016/j.ijsu.2006.12.005 17933694
12. Demicheli R Retsky MW Hrushesky WJ Baum M Gukas ID Jatoi I Racial disparities in breast cancer outcome: Insights into host-tumor interactions Cancer 110(9):1880-1888. 2007 Nov 1 10.1002/cncr.22998
13. Retsky M Bonadonna G Demicheli R Folkman J Hrushesky W Valagussa P Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients Breast-Cancer-Research 2004, 6:R372-R374. http://breast-cancer-research.com/content/6/4/R372 468653 15217504 10.1186/bcr804
14. Baum M Cuzick J Howell A Buzdar A on behalf of the ATAC Trialists' Group and Demicheli R Greco M Retsky M Hrushesky W on behalf of the Milan Institute An exploration of relapse data by hazard rate as a means of developing biological insights into the natural history and treatment of breast cancer: Data from the 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) trial and the Milan Institute database [abstract] ASCO 2005 http://meeting.ascopubs.org/cgi/content/abstract/23/16_suppl/ 612
15. Baum M Demicheli R Hrushesky W Retsky M Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases? Eur J Cancer 2005, 41(4):508-515. 10.1016/j.ejca.2004.09.031 15737554
16. Naumov GN Folkman J Straume O Tumor dormancy due to failure of angiogenesis: Role of the microenvironment Clin Exp Metastasis 2008.
17. Hormbrey E Han C Roberts A McGrouther DA Harris AL The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis Clin Cancer Res 2003, 9(12):4332-4339. 14555503
18. Folkman J Kalluri R Cancer without disease Nature 427,(6977):787. 10.1038/427787a
19. Whitworth A Endostatin: Are we waiting for Godot? J Natl Cancer Inst 98(11):731-733.
20. Zorick TS Mustacchi Z Bando SY Zatz M Moreira-Filho CA Olsen B Passos-Bueno MR High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours Eur J Hum Genet 2001, 9(11):811-814. 10.1038/sj.ejhg.5200721 11781696
21. Bénard J Béron-Gaillard N Satgé D Down's syndrome protects against breast cancer: Is a constitutional cell microenvironment the key? Int J Cancer 113, 1:168-170. 10.1002/ijc.20532
22. Satgé D Sasco AJ Pujol H Rethoré MO Breast cancer in women with trisomy 21 Bull Acad Natl Med 2001, 185(7):1239-1252. 11975321
23. Greene AK Kim S Rogers GF Fishman SJ Olsen BR Mulliken JB Risk of vascular anomalies with Down syndrome Pediatrics 2008, 121(1):e135-140. 10.1542/peds.2007-1316 18166531
24. Lange R Guenther T Busch R Hess J Schreiber C The presence of Down syndrome is not a risk factor in complete atrioventricular septal defect repair J Thorac Cardiovasc Surg 2007, 134(2):304-310. 10.1016/ j.jtcvs.2007.01.026 17662766
25. Herbst RS Lee AT Tran HT Abbruzzese JL Clinical studies of angiogenesis inhibitors: The University of Texas MD Anderson Center Trial of Human Endostatin Curr Oncol Rep 2001, 3(2):131-140. 10.1007/s11912-001-0013-8 11177745
26. Herbst RS Mullani NA Davis DW Hess KR McConkey DJ Charnsangavej C O'Reilly MS Kim HW Baker C Roach J Ellis LM Rashid A Pluda J Bucana C Madden TL Tran HT Abbruzzese JL Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin J Clin Oncol 20(18):3804-3814. 10.1200/ JCO.2002.05.102
27. Herbst RS Hess KR Tran HT Tseng JE Mullani NA Charnsangavej C Madden T Davis DW McConkey DJ O'Reilly MS Ellis LM Pluda J Hong WK Abbruzzese JL Phase I study of recombinant human endostatin in patients with advanced solid tumors J Clin Oncol 20(18):3792-3803. 10.1200/JCO.2002.11.061
28. Mundhenke C Thomas JP Wilding G Lee FT Kelzc F Chappell R Neider R Sebree LA Friedl A Tissue examination to monitor antiangiogenic therapy: a phase I clinical trial with endostatin Clin Cancer Res 2001, 7(11):3366-3374. 11705849
29. Boehm T Folkman J Browder T O'Reilly MS Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature 390(6658):404-407. 10.1038/37126
30. Pawliuk R Bachelot T Zurkiya O Eriksson A Cao Y Leboulch P Continuous intravascular secretion of endostatin in mice from transduced hematopoietic stem cells Mol Ther 2002, 5(4):345-351. 10.1006/ mthe.2002.0572 11945060
31. KuoCJ Farnebo F Yu EY Christofferson R Swearingen RA Carter R von Recum HA Yuan J Kamihara J Flynn E D'Amato R Folkman J Mulligan RC Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer Proc Natl Acad Sci USA 98(8):4605-4610. 10.1073/pnas.081615298
32. Sund M Hamano Y Sugimoto H Sudhakar A Soubasakos M Yerramalla U Benjamin LE Lawler J Kieran M Shah A Kalluri R Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors Proc Natl Acad Sci USA 102(8):2934-2939. 10.1073/pnas.0500180102
33. Lee TY Tjin Tham Sjin RM Movahedi S Ahmed B Pravda EA Lo KM Gillies SD Folkman J Javaherian K Linking antibody Fc domain to endostatin significantly improves Endostatin half-life and efficacy Clin Cancer Res 14(5):1487-1493. 10.1158/1078-0432.CCR-07-1530
34. Xu F Ma Q Sha H Optimizing drug delivery for enhancing therapeutic efficacy of recombinant human endostatin in cancer treatment Crit Rev Ther Drug Carrier Syst 2007, 24(5):445-492. 18197781
35. Wu FP Hoekman K Meijer S Cuesta MA VEGF and endostatin levels in wound fluid and plasma after breast surgery Angiogenesis 2003, 6(4):255-257. 10.1023/B:AGEN.0000029410.32264.b0 15166493
36. Errera FI Canani LH Yeh E Kague E Armelin-Corrêa LM Suzuki OT Tschiedel B Silva ME Sertié AL Passos-Bueno MR COL18A1 is highly expressed during human adipocyte differentiation and the SNP c.1136C > T in its "frizzled" motif is associated with obesity in diabetes type 2 patients An Acad Bras Cienc 2008, 80(1):167-177. 18345385
37. Roh JL Sung MW Kim KH Suppression of accelerated tumor growth in surgical wounds by celecoxib and indomethacin Head Neck 2005, 27(4):326-332. 10.1002/hed.20167 15719392
38. Da Costa ML Redmond HP Bouchier-Hayes DJ Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery J Surg Res 2001, 101(2):111-119. 10.1006/ jsre.2001.6250 11735264
39. Kaya M Wada T Nagoya S Yamashita T Prevention of postoperative progression of pulmonary metastases in osteosarcoma by antiangiogenic therapy using endostatin J Orthop Sci 2007, 12(6):562-567. 10.1007/ s00776-007-1179-1 18040639
40. Wood PA Bove K You S Chamber A Hrushesky WJM Cancer growth and spread are salutatory and phase-locked to the reproductive cycle through mediators of angiogenesis Mol Cancer Ther 2005, 4(7):1065-1075. 10.1158/ 1535-7163.MCT-05-0028 16020664